"Montreal-based BioAmber cautions that failing to achieve its financing and restructuring goals will likely result in the company filing for bankruptcy." Reported less than 2 weeks ago. So ... who's keeping stock price lower and why? To make financing easier?
Market Data 
Markets 
AI
